X0609 4 2026-05-07 0001099800 Edwards Lifesciences Corp EW 0001665141 Zovighian Bernard J false ONE EDWARDS WAY IRVINE CA 92614 1 1 CEO 0 Common Stock 2026-05-07 4 A 0 43800.0000 0.0000 A 124057.6499 D Common Stock 2026-05-07 4 F 0 4153.0000 83.2000 D 119904.6499 D Common Stock 2026-05-08 4 G 0 4222.0000 0.0000 D 115682.6499 D Common Stock 2026-05-08 4 F 0 5398.0000 82.7600 D 110284.6499 D Common Stock 2026-05-11 4 G 0 5489.0000 0.0000 D 104795.6499 D Common Stock 2026-05-08 4 G 0 4222.0000 0.0000 A 16261.5511 I By Trust Common Stock 2026-05-11 4 G 0 5489.0000 0.0000 A 21750.5511 I By Trust Common Stock 3733.5603 I 401(k) Employee Stock Option (Right to Acquire) 82.7600 2026-05-07 4 A 0 245300.0000 0.0000 A 2027-05-07 2033-05-06 Common Stock 245300.0000 245300.0000 D Performance Rights 2026-05-07 4 A 0 43800.0000 0.0000 A 2029-05-07 Common Stock 43800.0000 43800.0000 D These restricted stock units were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. These options were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal monthly installments. Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2029. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 200% of the Target Awards. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Linda J. Park, Attorney-in-Fact 2026-05-11